These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12036528)

  • 21. Assessment of flow profile of left anterior descending coronary artery in hypertrophic cardiomyopathy by transesophageal pulsed Doppler echocardiography.
    Tomochika Y; Tanaka N; Wasaki Y; Shimizu H; Hiro J; Takahashi T; Tone T; Matsuzaki H; Okada K; Matsuzaki M
    Am J Cardiol; 1993 Dec; 72(18):1425-30. PubMed ID: 8256738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doppler evidence of abnormal intracavitary systolic and diastolic flow in hypertrophic cardiomyopathy with midventricular obstruction.
    Barbier P; Bartorelli AL
    Am Heart J; 1993 Aug; 126(2):483-7. PubMed ID: 8338032
    [No Abstract]   [Full Text] [Related]  

  • 23. [Assessment of coronary flow reserve in patients with hypertrophic cardiomyopathy using transthoracic color Doppler echocardiography].
    Asami Y; Yoshida K; Hozumi T; Akasaka T; Takagi T; Kaji S; Kawamoto T; Ogata Y; Yagi T; Morioka S; Yoshikawa J
    J Cardiol; 1998 Oct; 32(4):247-52. PubMed ID: 9833231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.
    Sekine T; Daimon M; Hasegawa R; Teramoto K; Kawata T; Tanaka N; Takei Y; Takazawa K; Yoshida K; Komuro I
    Heart Vessels; 2006 Nov; 21(6):350-5. PubMed ID: 17143709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
    Bonow RO; Dilsizian V; Rosing DR; Maron BJ; Bacharach SL; Green MV
    Circulation; 1985 Oct; 72(4):853-64. PubMed ID: 4040821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.
    Bonow RO; Vitale DF; Maron BJ; Bacharach SL; Frederick TM; Green MV
    J Am Coll Cardiol; 1987 May; 9(5):1108-16. PubMed ID: 3571751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy.
    Sherrrid MV; Mahenthiran J; Casteneda V; Fincke R; Gasser M; Barac I; Thayaparan R; Chaudhry FA
    Am J Cardiol; 2006 Jan; 97(1):106-12. PubMed ID: 16377293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered left ventricular diastolic function post-atrial pacing in coronary artery disease and left ventricular hypertrophy: further insights by pulmonary venous flow analysis.
    Hoffmann R; Lambertz H; Thoennissen G; Flachskampf FA; Hanrath P
    Eur Heart J; 1994 Aug; 15(8):1096-105. PubMed ID: 7988602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary flow dynamics and reserve assessed by transesophageal echocardiography in obstructive hypertrophic cardiomyopathy.
    Memmola C; Iliceto S; Napoli VF; Cavallari D; Santoro G; Rizzon P
    Am J Cardiol; 1994 Dec; 74(11):1147-51. PubMed ID: 7977076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of coronary flow with transthoracic color Doppler echocardiography in patients with hypertrophic cardiomyopathy.
    Ferreiro DE; Cianciulli TF; Saccheri MC; Lax JA; Celano L; Beck MA; Gagliardi JA; Kazelián LR; Neme RO
    Echocardiography; 2013 Nov; 30(10):1156-63. PubMed ID: 23662893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of coronary flow abnormalities in obstructive type hypertrophic cardiomyopathy: noninvasive assessment by transthoracic Doppler echocardiography.
    Celik S; Dagdeviren B; Yildirim A; Gorgulu S; Uslu N; Eren M; Gurol T; Ozen E; Tezel T
    J Am Soc Echocardiogr; 2004 Jul; 17(7):744-9. PubMed ID: 15220899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.
    Yasar AS; Turhan H; Erbay AR; Karabal O; Bicer A; Sasmaz H; Yetkin E
    J Invasive Cardiol; 2005 Feb; 17(2):73-6. PubMed ID: 15687528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of diastolic paradoxical jet flow in a patient with hypertrophic cardiomyopathy with midventricular obstruction: dissociation between systolic and diastolic intracavitary flow dynamics.
    Yamamoto K; Masuyama T; Nishikawa N; Tanouchi J; Hori M
    J Am Soc Echocardiogr; 1993; 6(6):628-30. PubMed ID: 8311972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
    Maron BJ; Nishimura RA; McKenna WJ; Rakowski H; Josephson ME; Kieval RS
    Circulation; 1999 Jun; 99(22):2927-33. PubMed ID: 10359738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Green KJ; Wesley YE; Bonow RO; Arce J
    J Am Coll Cardiol; 1987 Oct; 10(4):733-42. PubMed ID: 3655141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different coronary blood flow increase in left ventricular hypertrophy due to hypertension compared to hypertrophic cardiomyopathy at elevated heart rate.
    Takechi S; Nomura A; Machida M; Fujimoto T; Kakinoki S; Komuro K; Kitabatake A
    Hypertens Res; 2003 Oct; 26(10):789-93. PubMed ID: 14621181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis.
    Tesic M; Djordjevic-Dikic A; Beleslin B; Trifunovic D; Giga V; Marinkovic J; Petrovic O; Petrovic M; Stepanovic J; Dobric M; Vukcevic V; Stankovic G; Seferovic P; Ostojic M; Vujisic-Tesic B
    J Am Soc Echocardiogr; 2013 Jul; 26(7):775-82. PubMed ID: 23643850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study.
    Nishimura RA; Hayes DL; Ilstrup DM; Holmes DR; Tajik AJ
    J Am Coll Cardiol; 1996 Feb; 27(2):421-30. PubMed ID: 8557915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Coronary flow characteristics in hypertrophic cardiomyopathy--a study with Doppler catheter].
    Negishi K; Handa S; Asakura Y; Iwanaga S; Ishikawa S; Wainai Y; Abe S; Tani M
    Kokyu To Junkan; 1991 Oct; 39(10):1021-7. PubMed ID: 1836067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in coronary blood flow dynamics between patients with hypertension and those with hypertrophic cardiomyopathy.
    Misawa K; Nitta Y; Matsubara T; Oe K; Kiyama M; Shimizu M; Mabuchi H
    Hypertens Res; 2002 Sep; 25(5):711-6. PubMed ID: 12452323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.